| Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 207.34 mm | 207.34 mm | 207.34 mm | 207.34 mm | 207.34 mm | 207.34 mm |
| Cash burn (monthly) | 7.23 mm | 3.42 mm | 15.97 mm | 14.02 mm | 7.40 mm | 8.77 mm |
| Cash used (since last report) | 31.31 mm | 14.82 mm | 69.18 mm | 60.74 mm | 32.05 mm | 37.99 mm |
| Cash remaining | 176.03 mm | 192.53 mm | 138.16 mm | 146.60 mm | 175.30 mm | 169.35 mm |
| Runway (months of cash) | 24.4 | 56.3 | 8.7 | 10.5 | 23.7 | 19.3 |
| 13F holders | Current |
|---|---|
| Total holders | 134 |
| Opened positions | 23 |
| Closed positions | 14 |
| Increased positions | 27 |
| Reduced positions | 28 |
| 13F shares | Current |
|---|---|
| Total value | 205.04 bn |
| Total shares | 53.47 mm |
| Total puts | 582.30 k |
| Total calls | 535.80 k |
| Total put/call ratio | 1.1 |
| Largest owners | Shares | Value |
|---|---|---|
| ATAI Atai Life Sciences | 6.91 mm | $47.10 mm |
| TCG Crossover GP I | 5.79 mm | $47.69 mm |
| Citadel Advisors | 5.41 mm | $34.11 bn |
| Integrated Core Strategies | 3.89 mm | $36.73 mm |
| TCG Crossover Management | 3.86 mm | $24.31 bn |
| Millennium Management | 3.76 mm | $23.67 bn |
| Vivo Opportunity Fund | 3.22 mm | $26.50 mm |
| ARK Investment Management | 2.01 mm | $12.63 bn |
| Vivo Capital | 1.61 mm | $10.13 bn |
| GMT Capital | 1.55 mm | $9.75 bn |
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 3 Feb 25 | Kabir Nath | Ordinary Shares | Payment of exercise | Dispose F | No | No | 4.31 | 15,516 | 66.87 k | 135,668 |
| 24 Oct 24 | Goldsmith George Jay | Ordinary Shares | Sell | Dispose S | Yes | No | 0 | 776,565 | 0.00 | 3,152,848 |
| 24 Oct 24 | Goldsmith George Jay | Ordinary Shares | Sell | Dispose S | No | No | 0 | 776,565 | 0.00 | 3,155,122 |
| 24 Oct 24 | Ekaterina Malievskaia | Ordinary Shares | Sell | Dispose S | Yes | No | 0 | 776,565 | 0.00 | 3,155,122 |
| 24 Oct 24 | Ekaterina Malievskaia | Ordinary Shares | Sell | Dispose S | No | No | 0 | 776,565 | 0.00 | 3,152,848 |
| 26 Sep 24 | Atai Life Sciences | Ordinary Shares | Sell | Dispose S | Yes | No | 6.05 | 2,660,000 | 16.09 mm | 6,905,774 |
